




Tom/Volume 65; Numer/Number 3/2014
ISSN 0423–104X
Aleksandra Zdrojowy-Wełna M.D., Wroclaw Medical University, Department of Endocrinology, Diabetology and Isotope Therapy, Pas-
teura St. 4, 50–367 Wrocław, Poland, tel. +48 71 784 25 47, e-mail: aleksandrazdr@gmail.com
The role of fat mass and obesity-associated gene (FTO)  
in obesity — an overview
Rola genu podatności na otyłość (FTO) w rozwoju otyłości — przegląd
Aleksandra Zdrojowy-Wełna1, Małgorzata Tupikowska2, Katarzyna Kolackov1,  
Grażyna Bednarek-Tupikowska1
1Medical University, Department of Endocrinology, Diabetology and Isotope Therapy, Wrocław, Poland 
2Medical University, Department of Dermatology, Venerology and Allergology, Wrocław, Poland
Abstract
Obesity is an epidemic of the 21st century. The magnitude of this problem stems from its increasing prevalence and numerous metabolic 
complications caused by excessive fat accumulation. The pathogenesis involves both environmental and genetic factors, and FTO (fat mass 
and obesity-associated gene) is one of the most significant among genes predisposing to obesity. The role of FTO polymorphism in the 
development of obesity has been confirmed in many studies, but the effect varies significantly in different ethnic groups. Moreover, the 
exact mechanisms of FTO influence are yet to be explained. The association between FTO and lifestyle factors such as diet and physical 
activity has been extensively studied in recent years. This paper presents current knowledge about the role of FTO gene in the develop-
ment of obesity and type 2 diabetes in different ethnic groups and the association between FTO polymorphism and lifestyle modifications 
predisposing to adiposity. (Endokrynol Pol 2014; 65 (3): 224–230)
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Streszczenie
Otyłość jest epidemią XXI wieku. Znaczenie tego problemu wynika zarówno z jego narastającej częstości, jak i wielu powikłań zdrowot-
nych, którym sprzyja nadmiar tkanki tłuszczowej. W patogenezie otyłości istotną rolę odgrywają czynniki środowiskowe i genetyczne, 
a spośród tych ostatnich jednym z najbardziej znaczących jest gen FTO (gen podatności na otyłość). Wpływ polimorfizmu FTO na rozwój 
otyłości potwierdzono w wielu pracach, lecz jego bezpośredni efekt zależy od pochodzenia etnicznego osób badanych. Ponadto wciąż 
niejasny jest dokładny mechanizm działania tego genu. W ostatnich latach intensywnie badano związek polimorfizmu genu FTO ze 
środowiskowymi czynnikami ryzyka otyłości, takimi jak dieta i wysiłek fizyczny. W niniejszej pracy przedstawiono obecny stan wiedzy 
o roli genu FTO w rozwoju otyłości i cukrzycy typu 2 w różnych grupach etnicznych oraz jego związek ze stylem życia, który predyspo-
nuje do nadmiernego gromadzenia tkanki tłuszczowej. (Endokrynol Pol 2014; 65 (3): 224–230)
Słowa kluczowe: otyłość; gen podatności na otyłość; polimorfizm; etniczność; zmiany stylu życia
Introduction
Obesity is one of the most serious problems in public 
health worldwide, leading to cardiovascular diseases, 
type 2 diabetes and several types of cancer. The preva-
lence of obesity is constantly increasing. Since 1980, 
the number of obese people has nearly doubled. This 
problem concerns not only adults (in 2008 more than 
1.4 billion were overweight), but also children (more 
than 40 million children under the age of five were 
overweight in 2011) [1].
That is why many scientific projects concentrate on 
the pathogenesis of excessive fat mass accumulation. 
Twin studies suggest the existence of genetic factors 
in human obesity [2] and estimate the heritability of 
obesity to be around 60-90% [3]. Recent advances in 
genomic technology (GWAS, genome wide association 
studies) have revealed more than 40 candidate genes 
that predispose individuals to obesity. One of them 
is fat mass and obesity-associated gene (FTO) — ac-
counting for approximately 22% of common obesity 
[4]. It is located on chromosome 16q12.2 and has nine 
exons. FTO is mainly expressed in the hypothalamus 
but also in other tissues (muscles, adrenal gland, and fat 
tissue). It encodes a 2-oxoglutarate-dependent nucleic 
acid demethylase and probably plays an important 
role in controlling energy homeostasis [5], nucleic acid 
demethylation and lipolysis [6].
FTO was first reported in 2007 by Frayling et al. for 
its association with type 2 diabetes and obesity [7]. Since 
then, the influence of FTO on obesity has been demon-
strated in many studies in different ethnic groups. FTO 
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contributes maximally to the variance in body mass index 
(BMI) in Europeans (0.34%) and East Asians (0.18%) [8, 9]. 
Although the role of FTO in the development of human 
obesity seems fairly certain, the exact mechanisms of this 
influence are yet to be explained. Another interesting 
problem is the interaction between genetic predisposition 
and lifestyle factors, such as diet and physical activity, 
which are currently the subject of extensive studies.
FTO and obesity in different ethnic groups
In the initial work by Frayling et al., the 16% of Euro-
pean adults who were homozygous for the A allele 
had 1.67-fold increased odds of obesity compared to 
homozygous for low risk T allele (39% of the popula-
tion) [7]. Later publications confirmed the association 
between FTO polymorphism and obesity risk in Cau-
casians [4, 10–14]. Meta-analyses [8, 15] have shown the 
effect of the predisposing genes on adiposity among 
individuals of European descent and are estimated 
to be 0.39kg/m2 per allele according to Spelios et al. 
and 0.28 kg/m2 according to Hertel et al. Most studies 
in the white population have concentrated on FTO 
rs9939609 polymorphism in the first intron [7, 12–15], 
which seemed to have the strongest influence on BMI 
mainly because of its prevalence — 45% for allele A due 
to HapMap. Only a few studies have referred to other 
introns — two, three [16], eight [17] and four [18].
Recently however, results of a new study have 
been released in which the entire FTO gene in total 
412 Kbp has been amplified in a group of 524 morbid 
obese and 527 lean Swedish children [19]. This is the 
first comprehensive variation map of the FTO gene, 
including both SNPs and small indels (small deletions 
and insertions), using new generation sequencing of 
pooled DNA - massive parallel sequencing (SOLiD). 
Scientists identified 19 obesity-associated SNPs. All of 
them are located in intron one, thus the authors con-
cluded that this is the only obesity-associated region 
of the FTO gene. Interestingly, ten of the identified 
SNPs have a stronger association than the commonly 
studied rs9939609, and rs62048402 has been shown 
to be the most significant one. This was confirmed in 
a recent study on a Latvian population [18] where SNPs 
rs62048402, rs9939609 and rs7561317 were associated 
with higher BMI with p-values of 0.0036, 0.0069 and 
0.015 respectively. The four top obesity-associated SNPs 
in a study by Almen et al. [19], with rs62048402 being 
the strongest one, lie within the potential regulatory 
region of intron one. Some transcription factors, such 
as the glucocorticosteroid receptor, bind there and this 
is the only known functional region of the compre-
hensive FTO map which may potentially explain the 
pathomechanism of related obesity.
The effect of the variant of FTO on adiposity varies 
among different populations [20]. In an Asian popula-
tion, initial studies did not confirm the role of FTO. Li 
et al. reported lower minor allele frequencies of FTO 
and no association with obesity in a Chinese population 
[21]. Similarly, a publication by Shimaoka et al. sug-
gested no influence of FTO on BMI or other metabolic 
traits except for insulin resistance [22]. But subsequent 
studies did reveal an association between FTO polymor-
phism and obesity in people of Asian descent [23–25]. 
A meta-analysis has been performed using data from 
32 populations, including 96,551 people from East and 
South Asia [26]. Each additional A-allele increased the 
odds of obesity by 1.25 and overweight by 1.13 com-
pared to normal weight controls. The study revealed 
that the effects of FTO polymorphism are similar to 
those observed in Europeans. It is thus possible that 
the effect of the FTO gene polymorphism can only be 
observed in more extensive studies of greater statistical 
power. An important difference is the lower Minor Al-
lele Frequency (MAF) of the FTO variant in South (0.32) 
and East (0.17) Asians than white Europeans (0.45), 
which results in a reduced role of FTO in propensity 
to obesity in general [26]. It should also be noted that 
the BMI cut-off values for obesity and overweight are 
lower for Asians than Europeans [27].
In African populations, the results of the studies are, 
so far, inconsistent. Bressler et al. [28] compared BMI 
and diabetes risk in Europeans and Africans. FTO poly-
morphisms were associated with higher BMI and diabe-
tes risk in Europeans, while in Africans only rs1421085 
was a determinant of obesity, but at the same time, 
a protective factor against diabetes. An interesting study 
carried out by Hennig et al. [29] showed that FTO varia-
tion did not influence BMI in a group of 2,208 Gambians 
who live in a traditional way and are leaner than typical 
Europeans. The authors suggested that the difference in 
lifestyle, especially in food excess and physical activity, 
might be the reason for the inconsistency in results with 
European studies. However, a study in postmenopausal 
women in the US [30] revealed no association between 
FTO risk alleles and obesity in black women, while in 
white women living in similar conditions, the influence 
was significant, and the MAF was comparable in both 
groups. This would suggest that ethnic differences 
predominate in influencing one’s lifestyle. But recent 
studies established the positive effect of FTO variation 
and obesity risk in individuals of African descent. First, 
Wing et al. [31] proved that rs8050136 and rs9939609 
were correlated with BMI in African-Americans. 
A study by Ademeyo et al. [17] showed effect size on BMI 
0.77 kg/m2 for rs9932411 and 0.70 kg/m2 for rs7191513 in 
West Africans and African-Americans. Hassainen et al. 
[32] genotyped SNPs, which are correlated with BMI in 
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Europeans, in nearly 10,000 African subjects. Most SNPs 
did not show any significant association with obesity 
except for rs3751812, which explained 0.31% average 
proportion of variance in BMI and rs9941349 — 0.30% of 
variance. The authors also suggest ruling out rs9939609 
and many other variants which are in linkage disequi-
librium (LD) with this variant in Europeans. 
The first study which focused on the Brazilian popula-
tion was carried out in 2012 [33]. Ramos et al. confirmed 
the association of the FTO variant with BMI in multi-ethnic 
Brazilian subjects. The homozygous for the risk allele A 
weighed about 3.1 kg more than TT-carriers.
There are few reports about FTO-related obesity risk 
in Oceanians [34, 35]. No significant association between 
FTO variation and adiposity has been reported.
 Peng et al. [20] meta-analysed 59 case-control 
studies and identified five polymorphisms (rs993609, 
rs17817449, rs1421085, rs8050136, rs1121980) associated 
with obesity in different ethnic groups. However, in 
some subgroups there was no correlation, for instance 
for rs993609 with Hispanic and Caucasian or rs8050136 
with Asians and Africans. This may be an effect of dif-
ferences in MAF or LD patterns in ethnic groups.
There have only been a few studies conducted in Po-
land. Kowalska et al. analysed the association between 
polycystic ovary syndrome and FTO polymorphism, 
showing its influence on weight, fat mass and insulin 
sensitivity [36], which is probably due to lower lipid 
oxidation in risk allele carriers [37]. Other authors have 
reported an association between rs9939609 polymor-
phism and obesity and cardiovascular risk in Polish 
children [38, 39]. The problem is becoming important, 
because the prevalence of adiposity - also in children - 
in our country is rapidly increasing.
Generally, the role of FTO gene in pathogenesis of 
obesity is proven, but the effect is variable in different 
ethnic groups. This partially explains the greater sus-
ceptibility of some groups to obesity. Moreover, studies 
concerning genetic predisposition to adiposity must 
include larger groups of subjects to achieve enough 
statistical power.
FTO-related obesity during lifetime
Another interesting aspect would be to assess the time 
when the effect of genetic predisposition becomes 
significant. A recent meta-analysis showed only 
a nominally significant association between FTO loci 
and birth weight [40], and the results were abolished 
after correction for multiple testing. Similar conclusions 
were made in earlier studies [7, 41], suggesting that 
FTO-related obesity tends to manifest later. However, 
the genetic predisposition was significant in a group of 
two-week-old newborns in a work by Lopez-Bermejo 
et al. [41]. The AA-homozygotes had 17% higher total, 
truncal, and abdominal fat mass than T-carrier neo-
nates. A Danish longitudinal study, representing a wide 
range of BMI in adolescence, showed that AA genotype 
predisposes to weight gain from birth to the age of 
7 years and later from adolescence and early adulthood 
onwards. [42] Generally, it seems that some alleles of 
FTO increase obesity risk since childhood [7, 41–43], 
but not due to higher birth weight. Another interesting 
observation was that the association between FTO and 
BMI is weaker in older men, probably because of loss 
of fat tissue connected with age [14]. At a younger age, 
the genetic predisposition has a stronger effect on BMI, 
which was also suggested in a recent work comparing 
FTO effect in four periods of adulthood [44]. No such 
works were conducted in Poland.
FTO and diabetes
The FTO gene has been investigated for its potential in-
fluence on type 2 diabetes (T2D). According to Frayling 
et al., each minor allele increased the odds of diabetes 
by 1.15-fold [7]. Most subsequent studies have shown 
that this association is only a result of adiposity in risk 
allele carriers [7, 11, 13, 14, 23, 45] and was invalidated 
after BMI adjustment. In contrast with this data, the 
MONICA Study revealed that rs9939609 A allele carri-
ers were 48% more likely to suffer from T2D; the risk 
persisted after BMI adjustment [12]. An observation 
carried out over a span of ten years in the HUNT study 
demonstrated higher T2D incidence in non-diabetic 
Scandinavians with risk allele. Although BMI adjust-
ment attenuated this correlation, it did not eliminate it 
[15]. A recent study in a Latvian population confirmed 
the association of SNPs in the first intron (rs11642015, 
rs62048402 and rs9939609) of FTO with T2D, which 
remained significant after correction for BMI. Inter-
estingly, the rs57103849 showed BMI independent 
association with younger age T2D diagnosis [18]. The 
rs57103849, which lies in the fourth intron outside the 
FTO gene cluster associated with obesity, was reported 
to correlate with insulin resistance independently of 
BMI [46].
Interesting results were also reported in studies 
among different ethnic groups [26, 47]. In an Indian 
population, rs9939609 showed an association with 
T2D but not with BMI. The authors concluded that 
Asians have generally lower BMI than Europeans and 
are more susceptible to T2D probably due to higher 
visceral obesity [47]. Other studies also reported that 
the association between FTO loci and T2D remains 
significant after a BMI adjustment [48, 49], but some 
showed BMI-dependent relation with T2D [23, 50]. 
A meta-analysis from Li et al. [26], combining data 
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of 96,551 Asians from 32 populations, confirmed the 
association of FTO variance and T2D, which was not 
abolished after an adjustment of BMI. However, this 
meta-analysis has been the subject of several limita-
tions, mentioned by Meyre [51]. Firstly, the authors 
adjusted the risk of T2D with BMI value, which does 
not sufficiently reflect fat body mass (especially vis-
ceral fat mass) in normal weight subjects. Secondly, 
data collected at one time-point may also be of limited 
value, because body weight might change due to 
diabetes therapy. That is why longitudinal studies, 
comparing newly diagnosed T2D cases to matched 
controls (as in the HUNT study) seem to be the most 
reliable. In Poland, an association between FTO varia-
tion and insulin sensitivity in a group of 136 women 
with PCOS was found (p = 0.025), but this effect was 
mediated by adiposity [36].
FTO gene predisposes to obesity and in this way 
it definitely predisposes to T2D as well. However, it is 
difficult to establish if the association is only adiposity-
dependent. Such studies would probably need to use 
methods like X-ray absorptiometry or MRI to assess fat 
mass volume rather than BMI.
FTO and diet
Although FTO’s role as the obesity susceptibility gene is 
fairly certain, its exact mechanism of influence remains 
unknown. Initial works showed that FTO encodes 
a 2-oxoglutarate-dependent nucleic acid demethylase 
and its mRNA was detected in many tissues. The high-
est expression was found in the hypothalamic sites 
that govern feeding behaviour, such as arcuate (ARC), 
paraventricular (PVN), dorsomedial and ventromedial 
(VMN) nuclei [52, 53]. Recently, studies have suggested 
that methylated single-stranded RNA, rather than 
DNA, may be the primary FTO substrate [54]. In mice, 
fasting was reported to decrease expression of the gene 
[52], however in rats upregulation has been detected 
[53, 54]. Results in animals have given the basis to 
subsequent publications assessing the role of FTO in 
regulation of energy balance in humans.
Studies have suggested that FTO-dependent risk 
of obesity is increased through higher energy intake 
rather than lower energy expenditure [43, 55]. In 
a group of 2,726 Scottish children (4-10 years), the A allele 
of rs9939609 was associated with increased food intake 
in test meals independently of body mass. Genetically 
predisposed subjects ingested meals with a 16% greater 
energy density than wild types, while the weight of 
chosen food did not differ significantly between these 
groups [43]. Results of other studies were consistent 
with this data, for example Timpson et al. revealed that 
risk allele carriers ingested more dietary fat and more 
dietary energy than non risk carriers [56]. This eating 
behaviour might be partially an effect of diminished 
satiety responsiveness, which has been reported both 
in children [57] and adults [58]. 
Interestingly, FTO may influence not only total 
energy, but also specific macronutrient ingestion. In-
creased fat intake in risk allele carriers was reported 
earlier [43, 55, 56]. Tanaka et al. performed recently 
a meta-analysis of macronutrient intake in popula-
tions of European descent and showed that rs1421085 
variant was associated with higher protein intake in-
dependently of BMI [59]. Corresponding results were 
demonstrated by the Malmo Diet and Cancer Study, 
where a higher percentage of energy from protein in 
diet was observed for A-allele carriers [60]. Subsequent 
studies in the same population also showed different 
food preferences related to FTO gene [61]. Risk allele 
was associated with a higher consumption of pastry, 
biscuits, ice-cream and fruit. In line with these results, 
A-allele carriers were reported to consume more 
meals per day and eat more energy dense foods [62]. 
However, in study of Corella et al. [63], no association 
between FTO and general food intake or food groups 
was found, but alcohol consumption in variant allele 
carriers was significantly lower than in wild-type sub-
jects. Interestingly, AA genotype subjects presented 
also the highest rate of under-reporting of energy 
intake (17%) compared to TT genotype (15.4%), which 
was also more frequent in obese population [61].
Generally, increased intake of energy dense foods, 
eaten additionally to main meals during the day, may 
partially explain FTO-related obesity development. 
Recently, an interesting work by Karra et al. [64] 
brought up a new possible explanation of FTO’s influ-
ence on diminished satiety. In this study ‘obesity-risk’ 
allele carriers (AA-homozygotes) exhibited attenu-
ated postprandial suppression of both hunger and 
acyl-ghrelin levels compared to TT-homozygotes. 
Ghrelin is an orexigenic hormone, often called ‘the 
hunger hormone’, increasing the intake of food [65] 
and shifting preference into meals rich in fat. The 
feeding phenotype caused by ghrelin is very similar 
to FTO A-allele influence. Risk-allele carriers not only 
presented higher levels of ghrelin in blood, but they 
also displayed different neural responses to ghrelin in 
the brain regions known to regulate appetite, reward-
processing and incentive motivation. With the use of 
functional MRI it was also shown that AA-subjects 
rated high-calorie food images as significantly more 
appealing in the postprandial state than TT-subjects. 
This study presents an interesting aspect of associa-
tion between FTO gene and adipocytokines, which are 
known to manage eating behaviour. Further studies in 
this subject are required [64].
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Some authors investigated also how a specific diet 
affects FTO-related obesity. For example, Razquin et al. 
[66] have demonstrated that a Mediterranean-based 
diet, rich in mono- and polyunsaturated fat, provides 
FTO risk allele carriers some protection against body 
weight gain after three years of nutritional interven-
tion. Also Corella et al. showed that high adherence to 
a Mediterranean diet can counterbalance the genetic 
susceptibility to obesity [63]. In the Malmo Diet and 
Cancer Study, fat intake was shown to accentuate the 
effect of FTO on obesity. In a group with high fat inges-
tion, large differences in percentage body fat depending 
on FTO were observed, and in a group with smaller 
fat intake, FTO changed fat mass less significantly 
[60]. Similar results were yielded in studies by Moleres 
et al. [67]. In line with these findings, in the Finnish 
Diabetes Prevention Study, an increase in BMI across 
FTO genotypes was accentuated by a diet with high 
fat, low carbohydrates and low fibre intake [68]. In the 
three-year follow-up of the study, individuals with the 
AA genotype did not differ from the other genotypes 
when they followed a diet low in energy. And a recent 
study confirmed a higher weight loss in A carriers of 
FTO rs9939609 polymorphism than in TT genotype 
subjects after three months of a hypocaloric diet [69]. 
Such results give new strength to dietary interventions, 
especially in patients with an inherited predisposition 
to obesity. 
FTO and physical activity (PA)
Physical activity is another important lifestyle inter-
vention, which may help to overcome the effect of 
the FTO gene on obesity-related traits. Vimaleswaran 
et al. showed a reduced, but still significant, effect 
of the rs1121980 polymorphism on both BMI and 
waist circumference in physically active individuals 
compared to an inactive group (20,374 European 
adults) [70]. Similarly, Andearsen et al. [11] found an 
interaction between the FTO rs9939609 genotype and 
self-reported physical activity on BMI levels in the 
Inter99 study sample. Not all studies, however, have 
confirmed the influence of physical activity on gene-
related obesity [71, 72]. Nevertheless, it is important 
that all mentioned works were based on self-reported 
activity measurement, which is an important limita-
tion. In the HELENA study, the physical activity was 
objectively assessed by accelerometry. Among ado-
lescents who spent at least 60 minutes participating 
in moderate to higher physical activity every day, the 
A allele was not associated with higher BMI or waist 
circumference, in contrast with inactive subjects [73]. 
Also in the Malmo diet and cancer cohort, A-allele in-
fluence on fat mass was eliminated only in the group 
with the highest leisure time activity (assessed with 
questionnaires and accelometry) [60].
The objectivity of assessing physical activity is not 
the only problem in all these studies. Generally, identi-
fying interactions between lifestyle and genetic variants 
requires much larger sample sizes than when detecting 
the simple effect of a gene on environment. The meta-
analyses might partially help to solve this problem, 
although authors have to compare results of the stud-
ies in which different methods were used. Kilpelainen 
et al. analysed data from 45 studies of 218,166 adults 
and nine studies of 19,268 children and adolescents, 
categorising subjects as ‘active’ or ‘inactive’. The effect 
of the FTO risk allele rs9939609 on BMI and obesity was 
almost 30% smaller in active adults than in inactive 
subjects. Interestingly, the FTO x PA interaction differed 
across geographical groups and was more significant 
in North Americans compared to Europeans. This may 
be caused by lower average physical activity in North 
Americans, so the lifestyle intervention may provide 
a greater reduction of obesity risk. Also, these differ-
ences might be caused by possible lower accuracy of 
PA measurement in Europeans (categorical variables) 
than in Americans (continuous variables). In children, 
no association between PA and FTO genes was found, 
what may be the effect of smaller sample size, but also 
inaccuracy of BMI as obesity measurement method in 
this age group [74].
Another important aspect of physical activity was 
reported in the population-based Malmo diet and 
cancer cohort [60]. The authors observed a tendency of 
interaction between leisure-time physical activity and 
FTO on total mortality (P = 0.07). Among TT-carriers, 
the highest vs lowest quintile of physical activity was 
associated with 33% reduced cardiovascular mortality, 
and 11% among A-allele carriers. These results suggest 
that FTO polymorphism modifies interaction between 
physical activity and cardiovascular mortality. There 
was no association between FTO and general mortal-
ity in a Swedish study [60]. Earlier, this correlation was 
significant in 362,200 Danish young men [75], where 
mortality was 42% reduced in TT genotype compared 
to A-allele carriers, independently of obesity. 
Conclusions
Variations of the FTO gene are risk factors for common 
obesity. The exact influence differs among ethnic popu-
lations due to genetic differences. It is also suggested 
that the effect on body mass of many polymorphisms 
may combine [76], which makes the analysis more diffi-
cult. Moreover, lifestyle modifications — especially diet 
and physical activity — may accentuate or attenuate 
genetic predisposition to obesity. 
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Gene/lifestyle interactions have become an im-
portant aspect of understanding the pathogenesis of 
excessive fat accumulation, but they are very difficult 
to assess. Studies concerning this problem must have 
enough power to detect these interactions, and exclude 
many limitations (mostly caused by self-reported data). 
However, more studies are needed, as their results could 
help to create more effective obesity treatments.
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